These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 12714703)

  • 1. Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage.
    Bianco NR; Perry G; Smith MA; Templeton DJ; Montano MM
    Mol Endocrinol; 2003 Jul; 17(7):1344-55. PubMed ID: 12714703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective roles of quinone reductase and tamoxifen against estrogen-induced mammary tumorigenesis.
    Montano MM; Chaplin LJ; Deng H; Mesia-Vela S; Gaikwad N; Zahid M; Rogan E
    Oncogene; 2007 May; 26(24):3587-90. PubMed ID: 17160017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications.
    Montano MM; Deng H; Liu M; Sun X; Singal R
    Oncogene; 2004 Apr; 23(14):2442-53. PubMed ID: 14676828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
    Kim K; Thu N; Saville B; Safe S
    Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta.
    Montano MM; Jaiswal AK; Katzenellenbogen BS
    J Biol Chem; 1998 Sep; 273(39):25443-9. PubMed ID: 9738013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen.
    Bentrem D; Dardes R; Liu H; MacGregor-Schafer J; Zapf J; Jordan V
    Endocrinology; 2001 Feb; 142(2):838-46. PubMed ID: 11159857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens.
    Montano MM; Katzenellenbogen BS
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2581-6. PubMed ID: 9122238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage.
    Bianco NR; Chaplin LJ; Montano MM
    Biochem J; 2005 Jan; 385(Pt 1):279-87. PubMed ID: 15456407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
    MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
    Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiestrogens induce growth inhibition by sequential activation of p38 mitogen-activated protein kinase and transforming growth factor-beta pathways in human breast cancer cells.
    Buck MB; Pfizenmaier K; Knabbe C
    Mol Endocrinol; 2004 Jul; 18(7):1643-57. PubMed ID: 15056732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen.
    Sripathy SP; Chaplin LJ; Gaikwad NW; Rogan EG; Montano MM
    Oncogene; 2008 Oct; 27(49):6376-84. PubMed ID: 18663360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
    Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells.
    Tonetti DA; Rubenstein R; DeLeon M; Zhao H; Pappas SG; Bentrem DJ; Chen B; Constantinou A; Craig Jordan V
    J Steroid Biochem Mol Biol; 2003 Oct; 87(1):47-55. PubMed ID: 14630090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
    Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC
    Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms.
    Platet N; Cunat S; Chalbos D; Rochefort H; Garcia M
    Mol Endocrinol; 2000 Jul; 14(7):999-1009. PubMed ID: 10894150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.